Navigation Links
Study of Mechanism of Action of Ibrutinib in Mantle Cell Lymphoma Published in Blood - Journal of the American Society of Hematology
Date:8/22/2013

re results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "goal", "should", "would", "project", "plan", "predict", "intend", "target" and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to us and are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance, expected liquidity or achievements to differ materially from those projected in, or implied by, these forward-looking statements. Factors that may cause such a difference include, without limitation, our need for substantial additional financing and the availability and terms of any such financing, the safety and/or efficacy results of clinical trials of our product candidates, our failure to obtain regulatory approvals or comply with ongoing governmental regulation, our ability to commercialize, manufacture and achieve market acceptance of any of our product candidates, for which we rely heavily on collaboration with third parties, and our ability to protect and enforce our intellectual property rights and to operate without infringing upon the proprietary rights of third parties. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements and no assurance can be given that the actual results will be consistent with these forward-looking statements. For more information about the risks and uncertainties that may affect our results, please see the Risk Factors section of our filings with the Securities and
'/>"/>
SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
2. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
3. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
4. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
5. GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
6. Astellas Confirms Interim Analysis in PREVAIL Study of XTANDI will Occur within Calendar Year 2013
7. Physicians Expect More Out of Tablet-Toting Pharmaceutical Sales Reps, Study Finds
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study
10. EntreMed Initiates Crossover Bioavailability And Food Effect Study Of ENMD-2076 Dosage Form To Be Used For Pivotal/Registration Clinical Trials
11. Recent Study Reveals Physicians Prefer Topical Delivery for Drug Delivery Technology, Such as a Transdermal Patch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015   CEFALY Technology ... nerve stimulation device specifically authorized for use prior to ... significant breakthroughs in migraine treatment at the EUROHEADPAIN - ... Valencia, Spain , from May 14-17, ... a meeting of EUROHEADPAIN, a major European research project ...
(Date:5/6/2015)... , May 6, 2015  MEI Pharma, Inc. (Nasdaq: ... of novel therapies for cancer, announced today that Daniel ... present at the Bank of America Merrill Lynch 2015 Health ... Pacific time from the Encore at the Wynn in ... presentation can be accessed at www.meipharma.com . A replay ...
(Date:5/6/2015)... -- - Annual List Showcases the 20 ... 2015 - Indegene Makes it to CIO ... Solution Providers for its Clinical, Commercial, and Marketing Solutions ... CIO Review (cioreview.com) has chosen Indegene (indegene.com) for its ... Providers 2015. The positioning is based on Indegene,s solutions ...
Breaking Medicine Technology:CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference 2CIO Review Selects Indegene for 20 Most Promising Pharma and Life Sciences Technology Solution Providers 2015 2
... Shows 51% Reduction in Intestinal Adenomas Suggesting,Possible Beneficial ... HILLS, Calif., March 07, 2007 /PRNewswire/ -- NutraCea,announced ... effect of rice bran,on the number of intestinal ... 2007 online edition of the prestigious British,Journal of ...
... Data Support Ability of Higher Doses to ... March 08, 2007 /PRNewswire-FirstCall/ -- La Jolla,Pharmaceutical ... its ongoing double-blind, placebo-controlled,randomized Phase 3 trial ... systemic lupus erythematosus ("lupus" or "SLE").,Analyses of ...
Cached Medicine Technology:British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 2British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 3British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer 4La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6La Jolla Pharmaceutical Announces Positive Interim Antibody Results,From Riquent Lupus Phase 3 Trial 7
(Date:5/6/2015)... A poker run to raise funds for the 2015 ... poker run will start at the United Veterans Club, 1914 W. ... the poker run, participants will visit checkpoints, drawing a card at ... at the end of the run. The run will start at ... Offsides Tavern, Fairmont American Legion, Hastings DAV post, Kearney American Legion ...
(Date:5/6/2015)... May 07, 2015 With recent headlines about ... Hong Kong by 6 men from Southern China, it is ... be a real concern for them. This is especially true ... who may attract unwanted attention through the property they own, ... they look. Fortunately for those individuals, families and companies that ...
(Date:5/6/2015)... Illinois (PRWEB) May 06, 2015 RPS Revolution ... take on the tried and true Rock Paper Scissors game ... With fun characters that encourage storytelling and easy to learn ... new twist on an old favorite. RPS Revolution ... it into whimsical characters that are grouped in set of ...
(Date:5/6/2015)... VA (PRWEB) May 06, 2015 ... services, today announced it won the Software & ... Award in the "Best Postsecondary Learning Management Solution" ... 2011 and has been finalists for this award seven ... innovation that stands out in the industry. , ...
(Date:5/6/2015)... May 06, 2015 On April 27, ... Plastic Surgery ,” compiled quotes about cosmetic surgery ... Aniston, pop singer Iggy Azalea, and Gwyneth Paltrow. For ... about having plastic surgery themselves; only a ... and its expectations of youth and beauty. (see: goo.gl/wSomih) ...
Breaking Medicine News(10 mins):Health News:Updated Contacts: Poker Run Fundraiser to Benefit National Veterans Golden Age Games 2Health News:Pacific Prime China Now Offering Kidnapping & Ransom Insurance 2Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3Health News:Plastic Surgery: Sixteen Celebrities Offer their Opinion about Going Under the Knife 2
... Institute of Allergy and Infectious Diseases (NIAID), part of the ... to discover and characterize novel adjuvants, substances that can be ... induce. "The goal of these awards is to ... vaccines," says NIAID Director Anthony S. Fauci, M.D. "Adjuvants can ...
... ... Trent Edwards to Fight Lou Gehrig,s Disease , ... Buffalo, N.Y. (Vocus) October 8, 2009 -- In honor of his well-known ... Buffalo Bills quarterback Trent Edwards will soon launch a new program that will help people ...
... less severe, experts say , THURSDAY, Oct. 8 (HealthDay News) ... H1N1 swine flu last spring aren,t seeing as much of ... states. , The possible reason: Many people in these spring-outbreak ... "herd immunity" is keeping a wider fall outbreak at bay, ...
... Va., Oct. 8 Thousands of people around the ... recite poetry and speak out to raise awareness and ... globe on Saturday, October 10, 2009. , "Discovering your ... Day 2009, stresses the need to hear the voices ...
... September 17, the City of Los Angeles recognized local dentist, ... to Smile, benefit at the grand opening of his new ... of the event. , The charity event, ,Reasons to ... to raise funds for the Northridge Hospital Medical Center. Supporters ...
... American Laser Centers, the leading provider of aesthetic services in ... oversee the continued growth and national expansion of the company. ... of managers, and is responsible for the strategic direction of ... of CEO from James McDermott. , American Laser Centers plans ...
Cached Medicine News:Health News:NIAID announces vaccine adjuvant discovery contracts 2Health News:Buffalo Bills Quarterback Trent Edwards Rallies Around The ALS Association 2Health News:Buffalo Bills Quarterback Trent Edwards Rallies Around The ALS Association 3Health News:Buffalo Bills Quarterback Trent Edwards Rallies Around The ALS Association 4Health News:In Some Cities, Spring Swine Flu May Be Easing Fall Outbreak 2Health News:In Some Cities, Spring Swine Flu May Be Easing Fall Outbreak 3Health News:In Some Cities, Spring Swine Flu May Be Easing Fall Outbreak 4Health News:Discovering the Voice of Hospice and Palliative Care Worldwide: World Hospice and Palliative Care Day - October 10, 2009 2Health News:Northridge Hospital Gets Over $10,000.00 in Donations From Local Dentist's Office Grand Opening Charity Event 2Health News:American Laser Centers Names Health Care Veteran Steven Straus CEO 2
Curved shafts with 2 mm angled platform. Wide serrated handle with dull finish....
Straight shafts with fine tips and dull finish. Insulated stop with tip gap set at 0.3 mm. Smooth handle....
Straight shafts with micro tips and sandblast finish. Insulated smooth handle....
Straight shafts with rounded tips. Smooth handle with dull finish....
Medicine Products: